History and progress of hypotheses and clinical trials for Alzheimer's disease.
Liu PP, Xie Y, Meng XY, Kang JS. · 2019
Read History and progress of hypotheses and clinical trials for Alzheimer's disease. by Liu PP, Xie Y, Meng XY, Kang JS. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6799833.txt.
Introduction
Liu and co-authors review the history and progress of hypotheses and trials for Alzheimer's disease. The disease brings progressive memory loss, psychiatric symptoms, and failing daily function. Its brain marks are shrinkage, amyloid plaques, and tau tangles. Many rival explanations compete: amyloid, tau spread, cholesterol signaling, mitochondria, calcium, blood vessels, inflammation, metals, and lymphatics among them.
No single cause has been proven. Trials built on each hypothesis have taught hard lessons. Infection theories, including herpes links, remain unproven as mechanisms. The authors argue that low metabolism plus faulty cell cleanup likely combine as causes. They further propose fluoxetine, a common antidepressant, as a candidate treatment worth testing. Puzzles remain wealthy in lessons for future interventions.
Catalog record
| CREATOR | Liu PP, Xie Y, Meng XY, Kang JS. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 149 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |